JP Morgan Sec LLC

Willis Towers Watson plc 8.3 Amend

RNS Number : 2033G
J.P. Morgan Securities LLC
22 July 2021
 

Ap19

 

 

AMENDMENT

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

16 July 2021

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

1,807,958  1.40

1,741,028  1.35

(2) Derivatives (other than options)

1,577,645  1.22

1,633,283  1.27

(3)Optionsandagreementstopurchase/sell

 

2,000  0.00

26,000  0.02

Total

3,387,603  2.62

3,400,311  2.64

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit(USD)

 

(Note 5)

Sale (Borrow Return)

 

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

 

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

63,000

 

100

 74

 174

 100

 100

 1,226

 7

 31

 40

 

600

 174

 8,179

 7

 40

 11

 1

 8

N/A

 

223.6442  USD

223.1250  USD

223.0804  USD

223.0300  USD

222.9526  USD

222.3600  USD

222.3400  USD

222.2900  USD

221.9100  USD

 

  250.0000  USD

223.0804  USD

222.3600  USD

222.3400  USD

221.9100  USD

221.7300  USD

221.7200  USD

221.4750  USD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD) (Note 5)

Equity Swap

Decrease Short

7

222.3600  USD

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price (USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5) (USD)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or   disposal   of   any  relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

  None

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    Yes

 

Date of disclosure

22 July 2021

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

 

 

 

 

 

 

SUPPLEMENTAL   FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND  RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   8.1(a)   & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS  (Note   1)

 

 

 

Productname,

e.g. call option

Written, orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2) (USD)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Put Option

 

Purchased

Written

Written

 

2,000

 2,000

24,000

 

230.00

 230.00

220.00

 

American

American

American

 

17/09/2021

20/08/2021

20/08/2021

 

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. 

Full  details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the   Rules. If in doubt, consult the Panel.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEUUSNRAOUBUAR